Longevity Peptides: Epithalon and SS-31 Research

Two short synthetic peptides. Two completely different mechanistic frameworks. Both examined in published preclinical research for effects on biological pathways implicated in cellular ageing and stress resistance.

• Epithalon (also written epitalon, the AEDG tetrapeptide) was developed at the Saint Petersburg Institute of Bioregulation and Gerontology. Characterised for effects on the telomere maintenance pathway and the pineal neuroendocrine axis
• SS-31 (also called elamipretide or Bendavia) is a Szeto-Schiller tetrapeptide developed in academic medicinal chemistry research at Weill Cornell. Mitochondrially targeted. Binds cardiolipin

These illustrate fundamentally different approaches to the molecular biology of cellular ageing.

One targets telomeres. The other targets mitochondria. Both pathways show up on the recognised hallmarks of biological ageing.

This article walks through chemistry, mechanism, pathway biology, and comparative research literature.

Third-person research voice. Research-use-only laboratory contexts.

Structural chemistry of epithalon and SS-31

Different design philosophies show up immediately in the chemistry.

Epithalon

Synthetic tetrapeptide: Ala-Glu-Asp-Gly (AEDG)

Developed under Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology.

Structural notes

• Smallest defined oligopeptide derived from research on epithalamin, a polypeptide preparation extracted from bovine pineal tissue
• Unmodified tetrapeptide
• Free N-terminal alpha-amino group
• Free C-terminal carboxylate
• No protective modifications or non-natural residues

Pharmacokinetic consequences

Small size and hydrophilic character produce characteristic behaviour examined in published research.

• Rapid clearance
• Short circulating half-life after peripheral administration

SS-31

Synthetic tetrapeptide: D-Arg-2,6-dimethylTyr-Lys-Phe-NH2

Designed in the laboratories of Hazel Szeto and Peter Schiller in the early 2000s as part of a programme examining mitochondrially targeted peptide structures.

The design logic

The alternating cationic and aromatic residue pattern was specifically designed to confer selective uptake into the mitochondrial matrix. The mechanism has been characterised in published research as independent of the mitochondrial membrane potential.

Key structural features

• 2,6-dimethyltyrosine residue
• D-arginine N-terminal residue
• C-terminal amidation

All three confer mitochondrial targeting selectivity and metabolic stability against peptidase cleavage.

Cardiolipin binding

The cardiolipin binding comes from electrostatic interaction. The cationic peptide pairs with the anionic cardiolipin headgroup of the inner mitochondrial membrane.

The broader SS peptide family

The published research includes a series of structural variants.

• SS-02
• SS-20
• TK0

All share the alternating cationic and aromatic pattern but differ in specific residues. These variants serve as research probes for examining the contribution of individual residues to mitochondrial accumulation and pathway engagement.

The selectivity for cardiolipin over other phospholipids, and the specificity for the inner mitochondrial membrane over other compartments, has been examined in published biophysical and cell biology research using fluorescently labelled peptide analogues, lipid binding assays, and subcellular fractionation.

Mechanism of epithalon in telomere pathway research

The proposed mechanism of epithalon has been characterised principally in the context of the telomere maintenance pathway.

What telomeres are

Telomeres are tandem repeats of the TTAGGG hexanucleotide sequence at chromosome ends. Published molecular biology research has characterised them as protecting chromosome termini from:

• Degradation
• Inappropriate recombination

How telomere length is maintained

The telomerase ribonucleoprotein complex does the maintenance. Two components:

• TERT (telomerase reverse transcriptase, the catalytic component)
• TERC (the telomerase RNA component)

Epithalon's proposed action

Published research has characterised epithalon administration in cell culture and in research animals as modulating telomerase activity. Reported effects on TERT expression in certain cell populations have been examined in published transcriptomic studies.

The mechanism characterised in the published literature involves an effect on the transcriptional regulation of telomerase components, potentially through interactions with chromatin or transcription factor complexes that remain incompletely characterised at the molecular level.

Pineal axis effects

Beyond the telomere pathway, epithalon has been examined in published research for effects on the pineal gland neuroendocrine axis, including:

• Melatonin biosynthesis
• Circadian regulation of pineal function

The relationship between the telomere pathway effects and the neuroendocrine effects has been examined as potentially involving common upstream regulators or as representing distinct downstream consequences of pineal pathway modulation.

Mechanism of SS-31 in mitochondrial pathway research

SS-31 is a cardiolipin-binding peptide that accumulates selectively in the inner mitochondrial membrane through electrostatic interaction with the cardiolipin headgroup.

What cardiolipin is

A dimeric phospholipid with four fatty acid chains and two negatively charged phosphate groups. Present almost exclusively in the inner mitochondrial membrane in mammalian cells. Characterised in published research as a structural component required for proper organisation of the electron transport chain complexes.

What SS-31 does to mitochondrial architecture

Cardiolipin binding has been characterised in published research as:

• Stabilising the architecture of the inner mitochondrial membrane
• Promoting assembly of respiratory chain supercomplexes

This produces measurable effects on the kinetics of electron transfer and proton pumping in isolated mitochondrial preparations.

Reactive oxygen species effects

Published research has also characterised SS-31 as reducing reactive oxygen species production at the electron transport chain. Proposed mechanisms include:

• Improved coupling efficiency
• Direct scavenging of certain radical species by the 2,6-dimethyltyrosine residue

The relationship between mitochondrial membrane potential, electron leak from the respiratory chain, and reactive oxygen species generation has been characterised extensively in published mitochondrial bioenergetics research. SS-31 effects are interpreted within that framework.

Mitochondrial permeability transition pore

The MPT pore is a regulated channel. Opening initiates apoptotic and necrotic cell death pathways. SS-31 exposure has been reported to modulate the threshold for pore opening in research model preparations.

Selectivity matters

The selectivity of SS-31 for the inner mitochondrial membrane distinguishes it mechanistically from non-targeted antioxidant compounds characterised in published comparative research.

Cristae architecture

Published research has characterised the consequences of SS-31 binding for the structural organisation of the inner membrane, with reported effects on:

• Curvature of the cristae structures
• Spatial arrangement of respiratory chain complexes within the lipid bilayer

Molecular dynamics simulations have provided a complementary structural perspective on the binding interaction characterised experimentally.

Cytochrome c retention

A secondary consequence of SS-31 binding: modulation of cytochrome c retention within the intermembrane space, with relevance to pathway biology characterised in published apoptosis research.

Pathway biology and ageing-related research

Both compounds have been examined across multiple ageing-related research contexts.

Epithalon research domains

Cell culture senescence

Published research has characterised effects on proliferative lifespan of certain fibroblast populations and on expression of cell cycle and senescence-related genes.

The replicative senescence phenomenon, originally characterised by Hayflick, describes the limited proliferative capacity of normal somatic cells in culture. The relationship between replicative senescence and telomere attrition has been established in published research, providing the molecular basis for examining telomere pathway-modulating compounds like epithalon in cell culture senescence models.

Aged rodent and primate models

Long-term experimental designs have examined epithalon for effects on:

• Neuroendocrine pathway markers
• Circadian rhythmicity
• Lifespan endpoints

Long-term experimental designs in research animals present methodological considerations: matched control groups, influence of housing and dietary regimens on baseline lifespan, and statistical treatment of survival data across multiple cohorts.

Published long-term cohort studies report effects on survival statistics and age-related pathology endpoints, although integration of these endpoints with the molecular mechanism remains an area of active investigation.

Pineal pathway biology

Effects on melatonin synthesis and circadian regulation of pineal function in research models. Effects on the diurnal pattern of melatonin secretion have been characterised using serial sampling protocols.

SS-31 research domains

Much broader pathway reach because mitochondrial function is central to cellular bioenergetics across virtually all tissue types.

Cardiac ischaemia-reperfusion

Major research domain. Published characterisation of SS-31 effects on:

• Infarct size
• Mitochondrial function
• Reactive oxygen species pathway markers

The cardiomyocyte is among the most mitochondrially rich cell types in the mammalian body, with mitochondria occupying approximately one-third of cellular volume.

Renal ischaemia-reperfusion

Reported effects on tubular mitochondrial function. The renal proximal tubule cells have particularly high mitochondrial density and oxidative metabolism, reflecting the energetic demands of solute reabsorption against electrochemical gradients.

Inherited mitochondrial disease

Studies in cells from patients with defined mitochondrial mutations and in animal models of mitochondrial myopathy. Effects on respiratory chain function and cellular energy metabolism.

Skeletal muscle

Effects on muscle mitochondrial function, oxidative capacity measured by high-resolution respirometry, and functional endpoints of muscle performance in aged research animals.

Neurodegeneration

Transgenic rodent models with characterised mitochondrial pathway involvement. Effects on neuronal mitochondrial function and pathway-relevant molecular markers.

NAD+ pathway compounds

Mitochondrial function and NAD+ pool size are biochemically linked. NAD+ precursor research compounds like NAD+ 500mg appear in published research alongside mitochondrial-targeted compounds as complementary probes of cellular bioenergetic pathway biology.

Integration of mitochondrial pathway research with broader ageing biology has been examined using paired analyses of mitochondrial function, cellular senescence markers, and tissue functional endpoints in research models.

Comparative research and pathway integration

Direct comparison of these two compounds in the same experimental system is uncommon. Different research traditions. Different timescales. Different endpoints.

Where each tradition lives

Epithalon Research concentrated in laboratories aligned with the Russian gerontological research tradition. Emphasis on:

• Neuroendocrine endpoints
• Telomere endpoints
• Long-term phenotypic endpoints

SS-31 Research concentrated in laboratories focused on mitochondrial bioenergetics. Emphasis on:

• Acute and subacute biochemical endpoints
• Physiological endpoints related to mitochondrial function

The intersection between the two research traditions remains limited in the published comparative literature.

The hallmarks of ageing framework

Both compounds engage pathways characterised in broader published ageing research as relevant to cellular senescence, age-related dysfunction, and stress resistance.

Published reviews of the molecular biology of ageing characterise:

• Telomere attrition as one recognised hallmark of biological ageing
• Mitochondrial dysfunction as another

Two compounds. Two different hallmarks. Both examined in research models of ageing biology, but through fundamentally different pathway entries.

Other potential pathway intersections

Less extensively examined for these specific compounds but areas of active investigation in the broader peptide research literature:

• Autophagy
• Nutrient-sensing pathways
• Inflammatory signalling

Procurement and reference material considerations

Different analytical workflows match the different structural classes.

Epithalon reference material

Analytical characterisation appropriate to a small unmodified tetrapeptide.

• Reversed-phase HPLC with ultraviolet detection for purity
• Electrospray mass spectrometry for intact-mass confirmation
• Amino acid analysis where required

Chromatographic challenge

Small size and hydrophilic character produce characteristic early retention on standard C18 reversed-phase columns. Method development for purity assessment may require:

• Ion-pairing reagents
• Hydrophilic interaction chromatography modifications

Both approaches are described in published method literature for short polar peptides.

Standard panel

• Karl Fischer water content
• Endotoxin testing
• Counter-ion quantification

SS-31 reference material

Analytical considerations related to its non-natural residues.

Identity confirmation

• Confirmation of the 2,6-dimethyltyrosine residue by mass spectrometry and amino acid analysis
• Confirmation of D-arginine configuration by chiral chromatography

Other endpoints

• Reversed-phase HPLC purity assessment
• Intact-mass confirmation
• Water content determination
• Endotoxin testing

Chromatographic considerations

The cationic character produces characteristic behaviour. Method development typically uses:

• Ion-pairing reversed-phase HPLC
• Specialised reversed-phase columns suitable for basic peptides

Stability

Published peptide stability literature has been described for both compound classes.

• For SS-31: attention to integrity of non-natural residues
• For epithalon: attention to absence of degradation products

Reconstitution protocols described in published research should be followed to preserve structural integrity.

Documentation of all analytical results on batch-specific certificates of analysis, including raw chromatographic and spectrometric data when requested, supports reproducible laboratory characterisation.

Broader pathway context and ageing biology research

Published research on the molecular biology of ageing has characterised a set of recognised hallmarks.

The recognised hallmarks

• Genomic instability
• Telomere attrition
• Epigenetic alterations
• Loss of proteostasis
• Deregulated nutrient sensing
• Mitochondrial dysfunction
• Cellular senescence
• Stem cell exhaustion
• Altered intercellular communication

This conceptual framework, articulated in influential published reviews, provides a backdrop for understanding how individual research compounds engaging specific pathways might be examined in research models of ageing biology.

Where epithalon and SS-31 fit

Epithalon Characterised effects on telomere maintenance and pineal pathway biology. Engages two of the hallmark pathways:

• Telomere attrition
• Altered neuroendocrine signalling

SS-31 Characterised effects on mitochondrial membrane architecture and electron transport chain function. Engages the mitochondrial dysfunction hallmark.

Pathway integration research

The integrated pathway biology of ageing has been examined using:

• Transcriptomic profiling in aged research animals
• Proteomic profiling in cellular senescence models
• Metabolomic profiling

Characterised molecular signatures have been used to evaluate the effects of candidate research compounds in preclinical settings.

Reference frameworks

Published research on caloric restriction, on rapamycin, and on other pharmacological probes of ageing biology provides comparison frameworks for understanding the relative contributions of distinct pathway interventions in research models.

The peptide research literature on epithalon and SS-31 represents one component of a broader landscape of published preclinical investigation into pharmacological modulation of ageing biology pathways. The molecular mechanisms underlying organismal ageing remain incompletely characterised and represent an area of active scientific investigation across multiple disciplines.

References

1. [1] Khavinson VK, Bondarev IE, Butyugov AA (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. PMID 12937682
2. [2] Anisimov VN, Khavinson VK, Provinciali M, et al. (2002). Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer. PMID 11857390
3. [3] Szeto HH (2014). First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. PMID 24506441
4. [4] Birk AV, Liu S, Soong Y, et al. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. Journal of the American Society of Nephrology. PMID 23687356
5. [5] Khavinson VK, Morozov VG (2003). Peptides of pineal gland and thymus prolong human life. Neuroendocrinology Letters. PMID 14523358
6. [6] Mitchell W, Ng EA, Tamucci JD, et al. (2020). The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. Journal of Biological Chemistry. PMID 32152226

Frequently asked questions